# Tofacitinib

## Xeljanz 5mg

##### 臨採

| 標題       | 說明                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|:-----------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 藥品代碼   | OXELJ                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 適應症     | Rheumatoid arthritis: Treatment of moderately- to severely-active rheumatoid arthritis (as monotherapy or in combination with methotrexate or other nonbiologic disease-modifying antirheumatic drugs) in adults who have had an inadequate response to, or are intolerant of, methotrexate.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 用法用量   | Rheumatoid arthritis, psoriatic arthritis 5 mg twice daily.Ulcerative colitis induction dose 10 mg twice daily (8-16 weeks), maintenance dose 5 mg twice daily.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 肝功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 腎功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 禁忌       | Hypersensitivity to tofacitinib or any component of the formulation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 副作用     | >10% Infection: Infection (20% to 22%) 1% to 10%: Cardiovascular: Hypertension (2%) Central nervous system: Headache (4%) Gastrointestinal: Diarrhea (4%) Genitourinary: Urinary tract infection (2%) Hepatic: Increased serum ALT (>3 x upper limit of normal; 1%) Infection: Serious infection (2% to 3%) Renal: Increased serum creatinine (<2%) Respiratory: Upper respiratory tract infection (5%), nasopharyngitis (4%) <1% (Limited to important or life-threatening): Abdominal pain, anemia, BK virus, cellulitis, cryptococcosis, cytomegalovirus disease, decreased heart rate, dehydration, dyspepsia, erythema, esophageal candidiasis, gastritis, hepatotoxicity, herpes zoster, increased creatine kinase, increased serum AST, interstitial pulmonary disease, liver steatosis, lymphocytopenia, malignant neoplasm, musculoskeletal pain, neutropenia, paresthesia, peripheral edema, pneumocystosis, pneumonia, prolongation P-R interval on ECG, pruritus, rhabdomyolysis, sinus congestion, skin carcinoma, skin rash, tendonitis, tuberculosis |
| 孕期建議   | No (limited) human data – animal data suggest low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 哺乳期建議 | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |

